We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
MPN-369: Potential Applications of Liquid Biopsy in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Systematic Review.
- Authors
Găman, Mihnea-Alexandru; Cozma, Matei-Alexandru; Dobrică, Elena-Codruta; Cretoiu, Sanda Maria; Găman, Amelia Maria; Diaconu, Camelia Cristina
- Abstract
In recent years, the use of liquid biopsy in solid and blood cancers has become an interesting option in the field of cancer diagnostics and cancer management. However, the potential applications of liquid biopsy have not been assessed in BCR-ABL1-negative myeloproliferative neoplasms (MPNs). To investigate the potential applications of liquid biopsy in MPNs. We performed a systematic search of Web of Science, PubMed/MEDLINE, and The Cochrane Library. Publications were retrieved from the inception of these databases until May 7, 2021. We only analyzed articles published in English, French, Italian, and Romanian. Only original articles or research letters exploring the potential applications of liquid biopsy in MPNs were included in the final analysis. Reviews, case reports, conference abstracts, and books were excluded. A systematic search was performed of Web of Science, PubMed/MEDLINE, and The Cochrane Library. In total, 198 potentially relevant papers were detected. Following the removal of duplicates (n=85), 113 records were screened. After the exclusion of irrelevant manuscripts, based on the screening of their titles and abstracts (n=81), we examined the full texts of 33 manuscripts. Finally, after we applied the exclusion and inclusion criteria, 27 original articles were included in this review. Overall, the 27 studies assessed included 1,336 patients diagnosed with classical MPNs and were conducted predominantly in Europe (n=22; n=10 for Italy, n=4 for France), followed by Asia (n=4), and Australia (n=1). Most studies were observational (cross-sectional: n=25) in design and included all subtypes of classical MPNs (n=8), whereas others analyzed ET in particular (n=7), PV in particular (n=3), or PV+ET (n=3). The analyzed studies investigated the levels of cell-free DNA (n=1), extracellular vesicles (n=7), microparticles (n=14), or circulating endothelial cells (n=5) in MPNs. Flow-cytometry was by far the most commonly employed method of detection (n=23). Based on the findings of this systematic review, we may hypothesize that in the near future, liquid biopsy might emerge as an important tool for the diagnosis and management of MPNs.
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2021, Vol 21, pS364
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/S2152-2650(21)01837-1